Skip to main navigation Skip to search Skip to main content

A DOSE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF UCB0599 IN STUDY PARTICIPANTS WITH PARKINSON'S DISEASE

Project: Research

Project Details

StatusActive
Effective start/end date02/16/24 → 12/1/26

Funding

  • UCB Biopharma SPRL: $59,577.31